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Satellite cells that reside on the myoﬁbre surface are crucial for the muscle homeostasis and regenera-
tion. Aging goes along with a less effective regeneration of skeletal muscle tissue mainly due to the
decreased myogenic capability of satellite cells. This phenomenon impedes proper maintenance and
contributes to the age-associated decline in muscle mass, known as sarcopenia. The myogenic potential
impairment does not depend on a reduced myogenic cell number, but mainly on their difﬁculty to
complete a differentiation program. The unbalanced production of reactive oxygen species in elderly
people could be responsible for skeletal muscle impairments. microRNAs are conserved post-
transcriptional regulators implicated in numerous biological processes including adult myogenesis.
Here, we measure the ROS level and analyze myomiR (miR-1, miR-133b and miR-206) expression in
human myogenic precursors obtained from Vastus lateralis of elderly and young subjects to provide the
molecular signature responsible for the differentiation impairment of elderly activated satellite cells.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
During aging, skeletal muscle is subjected to progressive loss of
muscle mass and strength, which is deﬁned as sarcopenia. This is an
age-related process known to be correlated to regenerative difﬁ-
culties by satellite cells (SCs), adult muscle stem cells, which
represent the main cell population involved in regeneration pro-
cesses of adult skeletal muscle. They are in the quiescent state
beneath the basal lamina, and upon activation they both proliferateh, Experimental and Forensic
Pavia, Italy.
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Inc. This is an open access article uand maintain undifferentiated phenotype or fuse each other and
differentiate into multinucleated myotubes. However, in elderly
subjects, the decreased muscle regenerative capability does not
appear to be due to a reduced number of myogenic cells [1e3]. The
mechanisms behind the impaired myogenic differentiation process
of elderly people are not fully understood, although they appear to
involve an imbalance between reactive oxygen species (ROS) pro-
duction and antioxidant enzyme activity and alterations in the gene
expression [2,4]. Among the ROS there are radicals as superoxide
anion (O2) that are normally produced by mitochondria at very
low level in the cell, but O2 production can increase producing
high level of other ROS as H2O2 [5]. ROS can modulate the tran-
scriptional proﬁles of many genes [6] and in suitable conditions
provoke damage into the cells. Myogenic regulatory factors (MRFs)
involved in differentiation programmes, including MyoD1
(Myogenic Differentiation 1) andMyog (Myogenin) [7] can regulate,
or be regulated by muscle-speciﬁc miRNAs, myomiRs (miR-1, miR-
133, miR-206), small non-coding RNAs that binding to mRNA tar-
gets interfere with protein synthesis. Emerging evidence hasnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ferentiation, proliferation and apoptosis [8e10]. ROS can also
modulate myomiRs since H2O2 exposure can induce concentration-
dependent apoptosis mediated by increasingmiR-1 expression [11].
We hypothesised that ROS-dependent MRF and myomiR can be
altered and involved in the myogenic impairment of elderly SCs. To
verify this we isolated SCs from skeletal muscle of young and aged
men and measured: (1) levels of intracellular O2 production; (2)
myomiR expression (also in myotubes); (3) gene expression proﬁle
of MRF (also in myotubes) including Pax3 (Paired Box 3 gene), Pax7
(Paired Box 7 gene), Myf5 (Myogenic Factor 5 gene), MyoD1, Myog,
and proliferation, atrophy, ubiquitin-proteasome and inﬂammation
pathways; (4) trans-membrane mitochondrial potential in living
cells. The data from this study suggest that the alteration of myo-
miR expression and ROS production in old SCs could contribute to
the impaired differentiation capacity of skeletal muscles in elderly
subjects.
2. Materials and methods
2.1. Samples
Muscle samples were derived from Vastus Lateralis muscle bi-
opsies using the percutaneous needle-biopsy [12]. Young
(22.8 ± 4.0 years; n ¼ 6) and old (76.6 ± 3.7 years; n ¼ 8) healthy
untrained male subjects underwent voluntary biopsies. These
subjects all provided written informed consent before participating
in the present study. This study was approved by the Ethics Com-
mittee for Biomedical Research, University of Chieti (PROT 1884
COET), and complied with the Declaration of Helsinky (as amended
in 2000). The inclusion criteria were normal ECG and blood pres-
sure, and absence of metabolic, cardiovascular, chronic bone/joint
and muscular diseases.
2.2. Cell cultures
The muscle biopsies were processed according to the pro-
cedures of Fulle et al. [13]. The cells were cultured for growth and
differentiation according to Pietrangelo et al. [2]. To assay the cell
proliferative capability were calculated the PDL (population
doubling level) at 20 days of culture. Pericytes were isolated ac-
cording to Dellavalle et al. [14]. The alkaline phosphatase expres-
sion was detected by enzymatic activity using the NBT/BCIP kit
(Roche).
2.3. Flow cytometric analysis
Human cell cultures were also evaluated by ﬂow cytometric
analysis for surface myogenic markers using CD56 (Mouse mono-
clonal antibody (Abcam, Cambridge, UK) and 5.1H11 policlonal
antibody (Developmental Studies Hybridoma Bank (DSHB), Iowa
City, Iowa, USA) [15]. The cells were detachedwith trypsin-EDTA 1X
in PBS without phenol red calcium and magnesium (EuroClone,
Milan, Italy) and washed with PBS. After washing, cells were
incubated with CD56 and 5.1H11 Abs, following the manufacturer
speciﬁcations and with the appropriate isotypes as internal con-
trols, at FACS Canto (BD, Franklin Lakes, NJ, USA), then the datawere
displayed using the FlowJo software (Tree Star, Ashland, OR, USA).
Data by FACS are mean ± SD of ﬁve independent experiments in
triplicates and expressed as percentage.
2.4. Fluorescence-activated cell sorting
To enrich the cell cultures in myogenic precursor, at least
1,000,000 cells per sample were detached with trypsin-EDTA inPBS without phenol red, calcium andmagnesium, and washed with
PBS. After washing, the cells were incubated for 30 min at 4 C with
speciﬁc primary antibodies for human myoblasts that targeted a
cell-surface protein, as CD56 and 5.1H11. After being washed with
PBS, the cells were incubated with Alexa Fluor 488 donkey anti-
mouse IgG (Molecular Probes, Life Technologies, Carlsbad, CA,
USA) for 30 min at 4 C, and then washed again in PBS. The human
myogenic precursors (expressing both CD56 and 5.1H11) were
isolated by ﬂuorescence-activated cell sorting (FACS) at FACS Aria III
(BD). These human CD56þ/5.1H11þ cells were replaced in petri
dishes and cultured in growth or differentiation medium for
microRNA isolations and further RT-PCR analysis.
2.5. Immunocytochemistry and immunoﬂuorescence analyses
To estimate the myogenic purity and the differentiative capacity
of cell cultures immunocytochemistry assays were performed as
described by Fulle et al. [13]. In addition, the myogenic differenti-
ation was determined by fusion index as the ratio of the number of
nuclei in differentiated myotubes (positive for MyHC) and the total
number of nuclei. Immunoﬂuorescence analysis was performed as
described by Dellavalle et al. [14]. The following antibodies were
used in this study: MF20 antibody at 1:5 dilution; anti smooth
alpha actin (Sigma, 1:300 dilution) and anti-desmin (Sigma, 1:50
dilution); NG2 (Chemicon, 1:250 dilution); anti PDGF receptor beta
(Cell Signaling Technologies, 1:500 dilution). After incubation,
samples were washed three times with BSA/PBS and then incu-
bated with the appropriate FITC or TRTC conjugated anti mouse or
anti-rabbit IgG for 1 h at RT. After three ﬁnal washes, the cover slips
were mounted on glass slides and analysed under an inverted
ﬂuorescent microscope (Nikon). Immunostaining and fusion index
data derived from at least 1000 cells counted in at least 10 different
randomly chosen optical ﬁelds of each culture.
2.6. Quantitative real-time PCR for myogenic transcriptional factors
RNAwas extracted with Purelink RNA Mini Kits (Invitrogen, Life
Technologies) and genomic DNA contaminationwas removed using
the TURBO DNA-Free kits (Ambion, Life Technologies). The RNAwas
quantiﬁed using a NanoDrop™ spectrophotometer. After 500 ng
reverse transcribed by Superscript III First-Strand Synthesis
SuperMix kit (Invitrogen, Life Technologies). Quantitative real-time
PCR (qPCR) was performed on 1:5 diluted cDNA, via Platinum Sybr
Green SuperMix-UDG (Invitrogen, Life Technologies), as 15 s at
95 C, 45 s at 60 C, for 40 cycles.
Primers: Pax3 FW TGTTCAGCTGGGAAATCCGAGACA, Pax3 REV
GTCGATGCTGTGTTTGGCCTTCTT, Pax7 FW AAGCACTGTGCCCT-
CAGGTTTAGT, Pax7 REV GTCGATGCTGTGTTTGGCCTTCTT, MyoD1
FW TGCTCCGACGGCATGATGGACTA, MyoD1 REV TTGTAG-
TAGGCGCCTTCGTAGCAGTT, Myf5 FW TGAGAGAGCAGGTGGA-
GAACTACT, Myf5 REV AGACAGGACTGTTACATTCGGGCA, Myogenin
FW TACAGATGCCCACAACCTGCACT, Myogenin REV TTTCATCTGG-
GAAGGCCACAGACA. Internal standard, GAPDH FW TGGTATCGTG-
GAAGGACTCATGAC, GAPDH REV ATGCCAGTGAGCTTCCCGTTCAGC.
The values represent the mean ± SD of three independent ex-
periments performed in triplicate. GAPDH was used as the house-
keeping gene, to normalise the mRNA levels, and the data are
shown as DCt.
2.7. NBT assay
The spectrophotometric NBT (Nitro blue tetrazolium chloride,
SIGMA-Aldrich, Milan, Italy) assay, based on the reduction of NBT in
Nitro blue-formazan in the presence of O2, was performed ac-
cording to Sozio et al. [16]. Conventionally, NBT assay is used to
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2.8. Measurement of ROS
Intracellular ROS were quantiﬁed by the 20,70-dichlorodihydro-
ﬂuorescein diacetate (H2DCF-DA Cat. No. D6883; Sigma) using a
SPECTRAmax Gemini XS microplate ﬂuorometer (Molecular De-
vices, Sunnyvale, CA, U.S.A.). The ﬂuorescence intensity represents
the mean of values registered during 5 min ± SEM [16].
2.9. Determination of mitochondrial membrane potential
The mitochondrial membrane potential was determined using
JC-1 (5,50,6,60-tetrachloro-1,10,3,30 tetraethylbenzimidazolylcarbo-
cyanine iodide/chloride; Molecular Probes), which is a ﬂuorescent
cationic carbocyanine dye that accumulates in the mitochondria.
The human myoblasts were plated in special-optics 96-well
(Corning-Costar, SIGMA-Aldrich). The cells were loaded with JC-1
(10 mM, 100 ml/well) for 15 min at 37 C. The ﬂuorescence in-
tensity of JC-1 was then measured at a constant temperature of
25 C using a microplate reader (SpectraMAX Gemini XS; J-aggre-
gates, excitation/emission 560/595 nm; JC-1 monomers, excitation/
emission 488/522 nm). The ﬂuorescence was recorded from each
well every for 10 min, in imaging buffer. The cells were then
stimulated with 100 nM H2O2 and all of the recordings were ac-
quired on a computer using SoftMax Pro (version 5.0). The values of
ﬂuorescence are expressed as ratio between red and green ﬂuo-
rescence value emission means ± SEM at four time-points.
2.10. RT-PCR on custom TaqMan array cards
RT-PCR was performed on myoblasts, using TaqMan low density
array (Applied Biosystems, Foster City, CA, USA) as described in
Fulle et al. [17]. The relative quantiﬁcation of target gene expression
was evaluated with the data from the SDS software, using the
arithmetical formula 2eDDCt, according to the comparative Ct
method, which represented the amount of the target normalised to
the endogenous control (GAPDH).
2.11. miRNA isolation and quantiﬁcation
Small RNA extractions from the young and old samples were
performed using PureLink miRNA Isolation kits (Invitrogen, Life
Technologies) following the manufacturer instructions. According
to the procedure of La Rovere et al. [18]. The ubiquitously produced
miR-16 was used as an internal control. miR-16 has been identiﬁed
as a candidate control gene as showing the least variability in cell
lines from Applied Biosystems (Application note TaqMan® Micro-
RNA Assays). In according to manufacturing indications, Ct values
do not change in our samples between proliferation and differen-
tiation condition. The relative quantiﬁcation of the miRNA targets
was carried out using the DCt formula (CtmiRNA of interest e CtmiR-16),
according to the Ct method. Three independent experiments were
performed in quintuplicate.
2.12. Western blotting
The myoblasts cultured in growth medium, were lysed in RIPA
buffer (SigmaeAldrich) supplemented with 1:100 protease inhibi-
tor cocktail (SigmaeAldrich), and 1:100 phosphatase inhibitor
cocktail (SigmaeAldrich). Protein extract was quantiﬁed by Bio-Rad
protein assay (Bio-Rad Laboratories, Milan, Italy). Total protein
mixes (140 mg) were separated on a 4e12% Bis-Tris Plus Gels (Life
Technologies) and transferred to a nitrocellulosemembrane (iBlot 2
Dry Blotting System (Life Technologies). After blocking for 1 h at RTwith 5% Skim-milk (SigmaeAldrich) in TBS buffer supplemented
with 0.1% Tween-20 (SigmaeAldrich), the membrane was incu-
bated overnight at 4 C with primary antibodies, as follows: HSP60
(D6F1) XP Rabbit mAb (Cell Signalling Technology, Danvers, MA,
USA) at 1:1000, HSP70 Antibody (Cell Signalling Technology) at
1:1000, GAPDH (Santa Cruz Biotechnology, INC) at 1:600. After
incubation with anti-rabbit or anti-mouse IgG, HRP-linked Anti-
body (Cell Signalling Technology) at 1:2000 for 1 h at RT. Immu-
nodetection was performed with the LiteAblot PLUS enhanced
chemiluminiscent substrate (EuroClone). Images were taken at
GelDoc machine (Bio-Rad). Western blots densitometric analysis
was performed with ImageJ software, a Java-based image analysis
package available free for download from the National Institutes for
Health (NIH).
2.13. Statistical analysis
Unpaired t-test with Welch's correction was performed old
versus young using Prism5 GraphPad software (Abacus Concepts,
GraphPad Software, SanDiego, CA, USA). A p-value <0.05 was
considered statistically signiﬁcant.
3. Results
3.1. Myogenic characteristics of cultures
The percentage of two surface markers/veþ (CD56 and 5.1H11
[19]) cells plus desmin/veþ cells and fusion index were considered
to depict the myogenic characteristics of our human myoblast
populations derived from young and old subjects (Table 1). In
young and old samples the percentage of desmin/veþ cells
(69.7 ± 8.5 and 64.3 ± 6.1 respectively) and CD56/veþ/5.1H11/veþ
cells (75.1 ± 7.0 and 66.4 ± 5.3, respectively) were not signiﬁcantly
different, conﬁrming a goodmyogenicity of our cultures. The FI was
signiﬁcantly different in young and old samples (52,1 ± 5,7 and
41,8 ± 8,1, respectively; *p < 0.05); while the percentage of unfused
desmin/veþ cells was higher in old samples than young ones
(42.5 ± 8.0 and 32.5 ± 9.6, respectively, *p < 0.05). Also the myo-
blasts proliferative capability after 20 days of culture was higher in
young respect to old samples (9.1 ± 1.3 PDL and 6.7 ± 1.1 PDL,
respectively, *p < 0.05).
3.2. MRF expression proﬁle of activated satellite cells and pericyte
characterization from young and old muscles
The analysis of the MRFs, including PAX-3, PAX-7, MYF5, MYOD
and MYOG, revealed that during proliferation state these genes
were signiﬁcantly down-regulated in the myoblasts from the
elderly than those from the young subjects (Fig. 1a). In the old
samples after 7 days in differentiation medium (Fig. 1a), the
expression of earlier genes such as Myf5 and MyoD was up-
regulated, while Myog was down-regulated with respect to the
young samples. This results in a reduced number of Myosin heavy
chain (MyHC, Fig. 1b) positive myotubes in old samples compared
to young ones despite the comparable amount of desmin positive
cells (Desm, Fig. 1b). However, the number of pericytes and their
typical markers, including alkaline phosphatase, PDGFRb (Platelet-
Derived Growth Factor Receptor Beta), NG2 (neural/glial antigen 2)
and a-SMA (alpha SmoothMuscle Actin) were not affected by aging
(Fig. 1c).
3.3. ROS measurement
Due to known implication of ROS in several cell signalling,
including the above-mentioned correlation between ROS and
Table 1
Myogenicity, Fusion Index, Unfused Desm/veþ percentage and proliferation rate (PDL). The percentage of myogenic cells in our cultures was analysed by immunostaining
for desmin and by FACS for two surface myogenic markers (CD56 and 5.1H11). Fusion index was determined by counting the number of nuclei in differentiated myotubes
(positive for MyHC) after 7 days of culture in differentiationmedium and reported as a percentage of the total number of nuclei; further theywere counted the unfused desmin
positive cells after 7 days differentiation. To assay the cell proliferative capability was calculated the PDL at 20 days of culture. Data by FACS are mean ± SD of ﬁve independent
experiments in triplicates and expressed as percentage. Immunostaining and FI data derived from at least 1000 cells counted in at least 10 different randomly chosen optical
ﬁelds of each culture. All data (n ¼ 6 young; n ¼ 8 old) are presented as mean ± SD *p < 0.05.
Samples Desmin/veþ cell % CD56þ/5.1H11þ cell % Fusion Index % Unfused desmin/veþ cell % PDL at 20 days of culture
Young 69.7 ± 8.5 75.1 ± 7.0 52.1 ± 5.7 32.5 ± 9.6 9.1 ± 1.3
Old 64.3 ± 6.1 66.4 ± 5.3 41.8 ± 8.1* 42.5 ± 8.0* 6.7 ± 1.1*
Fig. 1. Gene expression of MRFs in human myoblasts and myotubes of young and old subjects. (a) Levels of expression of myogenic genes (Pax3, Pax7, Myf5, MyoD1, Myogenin)
under proliferation (t0) and after myogenic induction (t7). Three independent experiments were performed, each in triplicate. Data are means ± SD and were analysed using
unpaired t-tests (old vs young). GAPDH was used as the housekeeping gene, to normalise the mRNA levels, and the data are shown as DCt (Ctgene of interest e CtGAPDH). Smaller DCts
indicate higher expression levels. *p < 0.01; **p < 0.001; ***p < 0.0001. (b) Immunoﬂuorescence analysis for the localization of Desm (green) and MyHC (red) in satellite cells and
myotubes respectively is shown. (c) Immunoﬂuorescence analysis for the localization of PDGFR b (green), NG2 (green), and a-SMA (red) in pericytes isolated from young and old
muscle biopsies; scale bar ¼ 50 mm. The alkaline phosphatase staining in isolated pericytes is also reported (c, upper panels); human ﬁbroblasts and human embryonic stem cells
were used as negative (CTR-) and positive (CTRþ) controls respectively; scale bar ¼ 50 mm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred
to the web version of this article.)
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by NBT assay and measurements of H2DCF-DA ﬂuorescence. Thebasal levels of intracellular ROS and more speciﬁc the O2 level
were signiﬁcantly higher in elderly myoblasts than in young ones
Fig. 2. ROS levels and time course of JC-1 ﬂuorescence emission. Quantitative analyses in myoblasts from young and old subjects of O2 (a) by NBT assay and intracellular ROS (b)
levels by H2DCF-DA ﬂuorescence. Data are mean ± SEM of three independent experiments each performed in quintuplicate. *p < 0.05, ***p < 0.0001. Panel (c) shows time course of
JC-1 ﬂuorescence ratio between red and green emission at four time-points. The myoblasts were followed for 10 min without or with addition of 100 nM H2O2. Data are
means ± SEM of three different experiments performed in quintuplicate. *p < 0.05, **p < 0.005.
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3.4. Trans-membrane mitochondrial potential measurement
We wondered if the trans-membrane mitochondrial potential
(DJm) could be affected by age impairing the homeostasis of these
organelles. The living myoblasts from the old muscle samples, in
the presence of JC-1 probe, showed a DJm signiﬁcantly lower than
for the young muscle samples. Moreover, the treatment with the
oxidant agent 100 nM H2O2, consistently decreased the DJm of
elderly myoblasts demonstrating speciﬁc difﬁculty to recover and
maintain the DJm to control values (Fig. 2c).
3.5. miRNA expression
TheMRF expression can affect myomiRs regulation, in particular
miR-1, miR-133b and miR-206, which at the same time modulate
the MRF family members affecting myogenesis. Furthermore, it is
demonstrated that high levels of ROS may increase the expression
of miRNAs, in particular miR-1. For these reasons we analysed the
expression of muscle-speciﬁc miRNA. During the proliferation state
(Fig. 3a), in old muscle samples miR-1was signiﬁcantly up-
regulated, miR-133b was slightly down-regulated and miR-206
did not signiﬁcantly change with respect to young muscle sam-
ples. During differentiation (Fig. 3b), both miR-1 and miR-133bwere signiﬁcantly up-regulated in elderly muscle respect to
young muscle samples, while miR-206 expression did not change.
All these miRNAs were up-regulated in differentiation than prolif-
eration conditions. The same analysis in the enriched cultures of
CD56/veþ/5.1H11/veþ myogenic precursors obtained by sorting
young and old myoblast populations, conﬁrmed the myomiR
expression results (data not shown).
3.6. Heat shock protein expression
Since miR-1 can inhibit Hsp60 and Hsp70, normal inhibitors of
apoptotic mitochondrial pathway [11] we assessed the Heat shock
proteins (HSPs) expression, ﬁnding them signiﬁcantly less
expressed in aged myoblasts than in young ones (Fig. 4e, f).
3.7. Speciﬁc pathway gene expression
In this scenario, speciﬁc transcriptome signature of selected
genes of proliferation, atrophy, ubiquitin-proteasome and inﬂam-
mation pathways related to regeneration and sarcopenia were
studied in satellite cells (Fig. 4a, b, c, d). The analysis of key cell-
cycle and proliferation genes showed signiﬁcant down-regulation
of cyclin dependent kinases (CDK1, CDK2, CDK4 and CDK7),
CCNB1(human cyclin B1), CCNE2 (human cyclin E2) (Fig. 4a).
CyclinB1 and CDK1 interact with each other and are involved in
Fig. 3. myomiR analysis in SCs isolated from young and old subjects. The expression levels of miR-1, miR-133, miR-206 were analysed during proliferation (a) and after 7 days
from myogenic induction (b). The ubiquitous miR-16 was used as housekeeping gene to normalize miRNA levels. Three independent experiments were performed in quintuplicates
and results are shown as DCt (CtmiRNA of interest e CtmiR-16). Data are mean ± SEM; **p < 0.005, ***p < 0.0001.
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E2 forms a complex with, and functions as a regulatory subunit of,
CDK2 and it is responsible for cell-cycle transition from G1 to S
phase. Instead DMTF1 and MSTN resulted up-regulated. Of the
atrophic pathway, FOXO1 was up-regulated while AKT1, PIK3CA,
MTOR genes, part of the PI3K-AKT-mTOR pathway that is involved
in protein synthesis as a positive regulator, andMAPK1were down-
regulated (Fig. 4b). Looking at the ubiquitin-proteasome system,
our selected genes (MUL1, PSMC6, UBA1 and UBE2A) were up-
regulated (Fig. 4c). As ROS related-apoptosis can be triggered by
alterations in the inﬂammatory system, the expression of some
cytokines were also analysed. The genes IL1R1, IL18, IL15 were up-
regulated while IL6 and LIF were down-regulated (Fig. 4d).4. Discussion
The impairment of myogenic differentiation in human elderlymyoblasts has been conﬁrmed in the present work by the reduced
fusion index values of humanmyoblasts, despite similar percentage
of desmin/veþ and CD56/veþ/5.1H11/veþ cells between young and old
myoblasts. In injured muscle or during growth, the SCs become
activated, and they proliferate (Pax3 and Pax7 highly expressed)
and activate Myf5, necessary for initial expansion of SCs [21], and
MyoD1, with the down-regulation of Pax3 and Pax7, followed by
Myog expression increase and terminal differentiation. SC self-
renewal is assured by a minority of SCs that maintain high Pax7
levels [22]. Indeedwe observed this typical MRFmodulation during
differentiation of our human myoblast populations derived from
young subjects, whereas in elderly subjects all MRF genes were
down-regulated.
Recent studies show that pericytes may have a profound impact
in skeletal muscle regeneration, ﬁbrosis and fat accumulation [23].
Our data clearly showed that pericytes are present in the elderly
muscles in a sufﬁcient number, and they express typical pericytic
Fig. 4. Speciﬁc signalling pathways and expression of Hsp60 and Hsp70 during proliferation in myoblasts derived from young and old subjects. Expression levels of genes
involved in proliferation (a), atrophy (b), ubiquitin-proteasome system (UPS) (c) and inﬂammation (d) pathways. Gene expression are analysed using RT-PCR with TaqMan low
density arrays. Data are means ± SEM of three independent experimental sets (n ¼ 4 each) and were analysed using unpaired t-tests (old vs young). e) Representative patterns of
Hsp60, Hsp70 and GAPDH (as loading control) expression in myoblasts deriving from two young and two old samples. f) Densitometric analysis expressed as AU (arbitrary units) of
all performed Western blots. **p < 0.005.
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exclude an impairment in their functions.
We have recently established that in the elderly skeletal muscle
a high percentage of the myogenic precursors are subjected to
spontaneous apoptosis triggered by caspase-9 [17]. It is knows that
the ROS accumulation, that is typical during ageing, through the
perturbation of pro- and anti-apoptotic rheostat, could trigger the
mitochondria-dependent apoptosis. The ROS could be produced by
different biochemical pathways, and in particular by mitochondrial
activity, which produces the superoxide anion (O2) as potentially
one of the most dangerous ROS [5]. Wemeasured a general oxidant
level, and in particular O2 production signiﬁcantly increased in
elderly myoblasts compare to young ones.
The intrinsic apoptotic process involves ROS-dependent trans-
membrane potential (DJm) alteration of mitochondria [24]. We
found DJm signiﬁcantly decreased in elderly myoblasts. Generally
the DJm decrease is linked to a complex mechanism that also in-
volves [Ca2þ]i increase and in turn leads to mitochondrial Ca2þ
uptake provoking O2 production via mitochondria uncoupling
[25]. The DJm decrease is demonstrated also after the exposure to
H2O2, when the DJm collapsed. We also found that the ROS, and
speciﬁcally O2 production, and miR-1 levels in elderly myoblasts
were signiﬁcantly higher than those in young ones. Therefore,
unbalanced mitochondrial activity and the presence of oxidative
stress alter critical cellular processes that in turn negatively affect
elderly myogenesis. miR-206 is normally up-regulated by Pax7/MyoD1 cascade and Myogenin. The lack of miR-206 modulation in
the elderly with respect to the young samples is consistent with
literature since miR-206 expression in skeletal muscle tissue was
found not different across time or between young and old samples
[26].
The speciﬁc MRF and miRNA modulation could be responsible
for impaired fusion index since myomiRs regulate metabolic
pathways and they are also altered in the aged male skeletal
muscles [26]. Here we show for the ﬁrst time that in old male
satellite cells miR-1 is up-regulated, miR-133b is down-regulated
during proliferation, while miR-206 is unaltered.
Data reported in the literature demonstrated that the modula-
tion of miR-1 and miR-133b has been linked to the activation of
apoptosis [25,27]. Moreover, it has been demonstrated in other
muscle cells that miR-1 participated in the oxidant-dependent
apoptotic insult [27] and that HSP70 [28] and HSP60 [29] are
miR-1 targets. Interestingly, we observed the up-regulation of miR-
1 only in proliferating elderly myoblasts and consequently the
protein content of Hsp60 and Hsp70 was signiﬁcantly reduced
compared to young ones.
Nevertheless, we found miR-1 and miR-133b up-regulated in
myotubes similarly to what observed in male myoﬁbers by Nielsen
et al. [26]. This suggests a speciﬁc role of elderly myoblasts in
determining the detrimental changes occurring in skeletal muscle
during aging. Both miR-1 and miR-133 are induced by SRF and play
important roles in myogenic proliferation and differentiation. In
E.S. Di Filippo et al. / Biochemical and Biophysical Research Communications 473 (2016) 462e470 469general, miR-1 pushes myoblasts toward terminal myogenic dif-
ferentiation [25].
The role of miR-133 during differentiation process is quite
controversial in literature [30e33]. Chen et al. showed thatmiR-133
hinders myoblast differentiation and promotes myoblast prolifer-
ation [30] while other groups showed that miR-133 promotes
myogenic differentiation [31e33]. This discrepancy might be due to
different experimental conditions and the different effects on car-
diac and skeletal myocytes. Thus it remains controversial whether
miR-133 promotes or inhibits muscle cell proliferation. Here, we
reported in elderly myotubes an impairment of differentiation
along with both the Myogenin down-regulation and miR-133b up-
regulation, accordingly with Chen et al. [30], who showed that miR-
133 overexpression repressed Myogenin in C2C12 cells.
Considering the impairment of elderly myoblasts in ROS man-
agement, we investigated some other pathways possibly involved
in oxidative stress defective state. Genes representative of cell cycle,
atrophy, ubiquitin-proteasome system (UPS) and inﬂammation
were dysregulated in elderly myoblasts. The genes involved in cell
cycle progression (CCNB1, CCNE2, CDK1, CDK2, CDK4 and CDK7)
were all down-regulated in old samples. This could explain the
lower proliferation rate at 20 days of cultures of elderly myoblasts
with respect to young ones. The highest percentage, after 7 differ-
entiation days, of unfused Desmin/veþ cell in our culture of elderly
samples, further conﬁrms the inability to progress to a terminal
differentiation. DMTF1 accordingly with the literature, we found
MSTN Myostatin overexpression along with MyoD1 and Pax3
expression down-regulation in elderly myoblasts [34]. Further-
more, also FOXO1 up-regulation, modulated by IGF-1/PI3K/AKT/
mTOR pathway [35], is consistent with the low levels of AKT-P
we previously found in aged myoblasts and myotubes [3]. More-
over, p53 overexpression [36] could depend on DMTF1, thus pro-
moting apoptosis [37]. It is worth mentioning, we previously
showed apoptotic commitment in elderly myoblasts [17]. The
down-regulation of PI3K and LIF along with the up-regulation of IL-
18 in elderly myoblasts and it is involved in apoptosis and tissue
destruction [38,39]. This situation seems further exacerbated by
ubiquitin proteasome system pathway. MUL1 that results up-
regulated in elderly samples, promotes mitochondrial fragmenta-
tion, and inhibits cell growth.
In conclusionwe showed that during aging activated SCs display
a complex picture of impaired regenerative potential, linked to
altered ROS production and miR-1 and miR-133 dysregulation. The
ﬁndings of this study suggest that myomiR modulation and ROS
inhibitors should be further explored for combined therapy in
sarcopenic muscles.
Conﬂict of interests
The authors declare that there is no conﬂict of interests.
Acknowledgements
We thank Dr. Vittore Verratti for his valuable skill in the needle-
biopsies execution and Christofer Berrie for his manuscript
generous editing. Sampaolesi is supported by Opening The Future
Campaign (EJJ-OPTFUT-02010), CARE-MI FP7 (#QPG-394601),
AFM-Telethon (#18073), Programmaﬁnanciering KUL PF/10/00300,
CARIPLO (2015-0634), FWO (#G088715N, #G060612N,
#G0A8813N), GOA (EJJ-C2161-GOA/11/012), IUAP-VII/07 (EJJ-
C4851-17/07-P) and OT#09-053 (EJJ-C0420-OT/09/053) grants.
Mancinelli, Pietrangelo and Fulle are supported by University “G.
d'Annunzio” of Chieti-Pescara local research grants and by MIUR
research grants [FIRB 2012 (RBFR12BUMH_005 Mancinelli), PRIN
2012 (2012N8YJC3_001 Pietrangelo) and PRIN 2010-2011(2010R8JK2X_007 Fulle)].
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.bbrc.2016.03.030.
References
[1] S. Beccaﬁco, C. Puglielli, T. Pietrangelo, R. Bellomo, G. Fano, S. Fulle, Age-
dependent effects on functional aspects in human satellite cells, Ann. N. Y.
Acad. Sci. 1100 (2007) 345e352.
[2] T. Pietrangelo, C. Puglielli, R. Mancinelli, S. Beccaﬁco, G. Fano, S. Fulle, Mo-
lecular basis of the myogenic proﬁle of aged human skeletal muscle SCs
during differentiation, Exp. Gerontol. 44 (2009) 523e531.
[3] S. Beccaﬁco, F. Riuzzi, C. Puglielli, et al., Human muscle satellite cells show age-
related differential expression of S100B protein and RAGE, Age Dordr. 33
(2011) 523e541.
[4] G. Fano, P. Mecocci, J. Vecchiet, et al., Age and sex inﬂuence on oxidative
damage and functional status in human skeletal muscle, J. Muscle Res. Cell
Motil. 22 (2001) 345e351.
[5] C.L. Quinlan, I.V. Perevoshchikova, M. Hey-Mogensen, A.L. Orr, M.D. Brand,
Sites of reactive oxygen species generation by mitochondria oxidizing
different substrates, Redox Biol. 1 (2013) 304e312.
[6] K. Gundersen, Excitation-transcription coupling in skeletal muscle: the mo-
lecular pathways of exercise, Biol. Rev. Camb. Philos. Soc. 86 (2011) 564e600.
[7] P.K. Rao, R.M. Kumar, M. Farkhondeh, S. Baskerville, H.F. Lodish, Myogenic
factors that regulate expression of muscle-speciﬁc microRNAs, PNAS 103
(2006) 8721e8726.
[8] Z.P. Huang, R. Espinoza-Lewis, D.Z. Wang, Determination of miRNA targets in
skeletal muscle cells, Methods Mol. Biol. 798 (2012) 475e490.
[9] M.J. Drummond, J.J. McCarthy, M. Sinha, et al., Aging and microRNA expression
in human skeletal muscle: a microarray and bioinformatics analysis, Physiol.
Genomics 43 (2011) 595e603.
[10] M. Sharma, P.K. Juvvuna, H. Kukreti, C. McFarlane, Mega roles of microRNAs in
regulation of skeletal muscle health and disease, Front. Physiol. 5 (2014) 239.
[11] J.M. Shookhoff, G.I. Gallicano, The emerging role of microRNAs in adult stem
cells, in: D.G. Phinney (Ed.), Adult Stem Cells e Biology and Methods of
Analysis, Springer New York Dordrecht Heidelberg, Humana Press, London,
2011, pp. 54e97.
[12] T. Pietrangelo, L. D'Amelio, C. Doria, R. Mancinelli, S. Fulle, G. Fano, Tiny
percutaneous needle biopsy: An efﬁcient method for studying cellular and
molecular aspects of skeletal muscle in humans, Int. J. Mol. Med. 27 (2011)
361e367.
[13] S. Fulle, S. Di Donna, C. Puglielli, et al., Age-dependent imbalance of the
antioxidative system in human satellite cells, Exp. Gerontol. 40 (2005)
189e197.
[14] A. Dellavalle, M. Sampaolesi, R. Tonlorenzi, et al., Pericytes of human skeletal
muscle are myogenic precursors distinct from satellite cells, Nat. Cell Biol. 9
(2007) 255e267.
[15] F. Trimarchi, A. Favaloro, S. Fulle, L. Magaudda, C. Puglielli, D. Di Mauro,
Culture of human skeletal muscle myoblasts: timing appearance and locali-
zation of dystrophin-glycoprotein complex and vinculin-talin-integrin com-
plex, Cells Tissues Organs 183 (2006) 87e98.
[16] P. Sozio, L.S. Cerasa, S. Laserra, et al., Memantine-sulfur containing antioxidant
conjugates as potential prodrugs to improve the treatment of Alzheimer's
disease, Eur. J. Pharm. Sci. 49 (2013) 187e198.
[17] S. Fulle, S. Sancilio, R. Mancinelli, V. Gatta, R. Di Pietro, Dual role of caspase
enzymes in satellite cells from aged and young subjects, Cell Death Dis. (2013)
e955.
[18] R.M. La Rovere, M. Quattrocelli, T. Pietrangelo, et al., Myogenic potential of
canine craniofacial satellite cells, Front. Aging Neurosci. 6 (2014).
[19] F.S. Walsh, M.A. Ritter, Surface antigen differentiation during human myo-
genesis in culture, Nature 289 (1981) 60e64.
[20] Y. Li, Y.L. Chen, Y.T. Xie, et al., Association study of germline variants in CCNB1
and CDK1 with breast cancer susceptibility, progression, and survival among
Chinese Han women, PLoS One (2013) e84489.
[21] S. Ustanina, J. Carvajal, P. Rigby, T. Braun, The myogenic factor Myf5 supports
efﬁcient skeletal muscle regeneration by enabling transient myoblast ampli-
ﬁcation, Stem Cells (2007) 2006e2016.
[22] M. Buckingham, F. Relaix, The role of Pax genes in the development of tissues
and organs: Pax3 and Pax7 regulate muscle progenitor cell functions, Annu.
Rev. Cell Dev. Biol. 23 (2007) 645e673.
[23] D. Costamagna, E. Berardi, G. Ceccarelli, M. Sampaolesi, Adult stem cells and
skeletal muscle regeneration, Curr. Gene Ther. 15 (2015) 348e363.
[24] S. Fulle, L. Centurione, R. Mancinelli, et al., Stem cell ageing and apoptosis,
Curr. Pharm. Des. 18 (2012) 1694e1717.
[25] T. Pietrangelo, E.S. Di Filippo, R. Mancinelli, et al., Low intensity exercise
training improves skeletal muscle regeneration in women by managing the
oxidative status, Front. Physiol. 6 (2015) 399.
[26] S. Nielsen, T. Hvid, M. Kelly, et al., Muscle speciﬁc miRNAs are induced by
testosterone and independently upregulated by age, Front. Physiol. 4 (2014)
E.S. Di Filippo et al. / Biochemical and Biophysical Research Communications 473 (2016) 462e470470394.
[27] W.H. Davin Townley-Tilson, T.E. Callis, Da-Zhi Wang, MicroRNAs 1, 133, and
206: critical factors of skeletal and cardiac muscle development, function, and
disease, Int. J. Biochem. Cell Biol. 42 (2010) 1252e1255.
[28] L. Yong-Eng, H. Chung-Ye, L. Yi-Ling, C. Ruei-Ming, MicroRNA-1 participates in
nitric oxide-induced apoptotic insults to MC3T3-E1 cells by targeting heat-
shock protein-70, Int. J. Biol. Sci. 11 (2015) 246e255.
[29] Z.X. Shan, Q.X. Lin, C.Y. Deng, et al., miR-1/miR-206 regulate Hsp60 expression
contributing to glucose-mediated apoptosis in cardiomyocytes, FEBS Lett. 584
(2010) 3592e3600.
[30] J.F. Chen, E.M. Mandel, J.M. Thomson, et al., The role of microRNA-1 and
microRNA-133 in skeletal muscle proliferation and differentiation, Nat. Genet.
38 (2006) 228e233.
[31] N. Liu, S. Bezprozvannaya, A.H. Williams, et al., microRNA-133a regulates
cardiomyocyte proliferation and suppresses smooth muscle gene expression
in the heart, Genes Dev. 22 (2008) 3242e3254.
[32] A. Care, D. Catalucci, F. Felicetti, et al., MicroRNA-133 controls cardiac hy-
pertrophy, Nat. Med. 13 (2007) 613e618.
[33] B. He, J. Xiao, A.J. Ren, et al., Role of miR-1 and miR-133a in myocardial
ischemic postconditioning, J. Biomed. Sci. 18 (2011) 18e22.[34] Y. Elkina, S. von Haehling, S.D. Anker, J. Springer, The role of myostatin in
muscle wasting: an overview, J. Cachexia Sarcopenia Muscle 2 (2011)
143e151.
[35] M. Sandri, L. Barberi, A.Y. Bijlsma, et al., Signalling pathways regulating muscle
mass in ageing skeletal muscle: the role of the IGF1-Akt-mTOR-FoxO
pathway, Biogerontology 14 (2013) 303e323.
[36] L. Barberi, B.M. Scicchitano, M. De Rossi, et al., Age-dependent alteration in
muscle regeneration: the critical role of tissue niche, Biogerontology 14
(2013) 273e392.
[37] D.P. Frazier, R.D. Kendig, F. Kai, et al., Dmp1 physically interacts with p53 and
positively regulates p53's stability, nuclear localization, and function, Cancer
Res. 72 (2012) 1740e1750.
[38] L.C. Hunt, E.M. Tudor, J.D. White, Leukemia inhibitory factor-dependent in-
crease in myoblast cell number is associated with phosphotidylinositol 3-ki-
nase-mediated inhibition of apoptosis and not mitosis, Exp. Cell Res. 316
(2010) 1002e1009.
[39] L. Austin, J. Bower, J. Kurek, N. Vakakis, Effects of leukemia inhibitory factor
and other cytokines on murine and human myoblast proliferation, J. Neurol.
Sci. 112 (1992) 185e191.
